Inpatient Drug Rehab in Philadelphia — Placement Advisors 24/7

The average cost of a 30-day inpatient program in Pennsylvania is $56,708 before insurance (National Center for Drug Abuse Statistics). With a commercial PPO or HMO policy, most callers pay between $3,000 and $12,000 out of pocket after insurance — and under PA Act 106, fully-insured group plans must cover at least 30 days of non-hospital residential rehab per year. Placement advisors verify your benefits for free.

If you have a fully-insured commercial group plan issued in Pennsylvania (Aetna, Cigna, Independence Blue Cross, Highmark, UnitedHealthcare, and others), Act 106 requires your plan to cover a minimum of seven days of detox, 30 days of non-hospital residential rehab, and 30 outpatient visits per year. Self-funded employer plans and individual marketplace plans may differ — placement advisors confirm what applies to your specific policy.

The Pennsylvania Act 106 minimum is 30 days per year for non-hospital residential rehab. Many callers do better in 60- or 90-day programs, especially for fentanyl, polysubstance, or dual diagnosis cases. Placement advisors present options at each length and explain what your insurance covers for extended care.

For fully-insured plans subject to PA Act 106, the only lawful prerequisite before accessing non-hospital residential or outpatient coverage is a written certification and referral from a licensed physician or licensed psychologist. Prior authorization cannot be used to deny or shorten coverage below the Act 106 minimum. The licensed programs we refer to handle this referral process directly.

Medical detox is a 3–10 day stabilization process before residential rehab begins. Licensed detox programs monitor vital signs around the clock and use medications to manage withdrawal — typically buprenorphine or methadone for opioids, benzodiazepines tapered down for alcohol, and careful cardiac monitoring for stimulant withdrawal. For fentanyl cases involving xylazine or medetomidine, the detox team needs to manage non-opioid withdrawal symptoms separately.

The licensed inpatient programs in our referral network include several that specifically understand xylazine and medetomidine withdrawal. These adulterants are now present in most Philadelphia street drugs, and withdrawal from them is not reversed by naloxone. When you call, tell the placement advisor whether your drug supply likely included xylazine or medetomidine so we route you to a program equipped to handle it.

Same-day admission is often possible for callers with commercial PPO coverage and no complicating medical conditions. For callers needing medical detox first, the placement advisor coordinates a detox bed and a downstream rehab bed simultaneously. Expect 12–48 hours from call to admission in most cases.

No. Inpatient Drug Rehab Philadelphia is a referral and placement resource — we are not a licensed treatment facility, detox center, or healthcare provider. Placement advisors verify your insurance and connect you with licensed inpatient programs that match your coverage, substance, and clinical needs. No clinical care, diagnosis, or treatment happens at our office.